McKesson Corporation - SIC # 5912 - DRUG STORES AND PROPRIETARY STORES

Ticker Exchange SIC # Website Latest Ticker
MCK New York 5912 www.mckesson.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for McKesson Corporation

CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue? - Sep 11th, 2026 12:21 pm
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? - Sep 11th, 2026 9:49 am
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - Sep 11th, 2026 9:29 am
McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights - Sep 10th, 2026 4:00 pm
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? - Sep 10th, 2026 11:46 am
Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026? - Sep 10th, 2026 10:21 am
Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue? - Sep 10th, 2026 9:30 am
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Sep 9th, 2026 7:00 am
Frazier Healthcare Partners Welcomes Tom Rodgers as Senior Partner - Sep 9th, 2026 6:00 am
3 Market-Beating Stocks for Long-Term Investors - Sep 8th, 2026 11:03 am
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates - Sep 8th, 2026 7:02 am
Reliant Infusion Names Tommy Pourmahram Chief Executive Officer - Sep 8th, 2026 7:00 am
Here's How CVS Is Focusing on Aetna's Profitability Turnaround - Sep 7th, 2026 8:50 am
McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy - Sep 6th, 2026 2:43 pm
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - Sep 4th, 2026 12:50 pm
Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report? - Sep 4th, 2026 9:30 am
McKesson Stock: Is MCK Outperforming the Healthcare Sector? - Sep 4th, 2026 6:43 am
Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore” - Sep 3rd, 2026 3:52 pm
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Sep 3rd, 2026 1:22 pm
Is Generics Still a Quiet Profit Engine for Cardinal Health? - Sep 3rd, 2026 6:22 am